Gilead’s CAR-T cell therapy shows promise in deadly brain cancer
A study led by Stephen Bagley of the Perelman School of Medicine found that a dual CAR-T cell treatment shrank tumors in 62% of patients with recurrent glioblastoma, a fatal brain cancer with few treatment options.
Hongjun Song of the Perelman School of Medicine says that it’s challenging to translate existing knowledge about adult neurogenesis from animal models to human studies.
An expensive Alzheimer’s lifestyle plan offers false hope, experts say
Jason Karlawish of the Perelman School of Medicine says that Dale Bresden’s unconventional Alzheimer’s treatment research and recommendations don’t adhere to the standards of medicine.
